S timulation of T lymphocytes results in the activation of several enzymes and transcription factors and, subsequently, a set of pleiotropic cellular responses that include proliferation and cytokine secretion. T cell activation via the TCR-CD3 complex is associated with the hydrolysis of inositol phospholipid, resulting in the production of inositol polyphosphates and diacylglycerols that regulate intracellular calcium and protein kinase C (PKC), 3 respectively. PKC consists of a family of isoforms divided into three groups based on enzymatic properties. These are the classical ␣, ␤, and ␥ novel (␦, ⑀, , , and ) and the atypical (, and /) subfamilies (reviewed in Ref. 1) . T lymphocytes express the PKC isoforms ␣, ␤⌱, ␦, ⑀, , , and . Activation of PKC may be mimicked in vitro by phorbol esters such as PMA. PKC has been shown to play a key role in T cells, and various studies have been conducted in an attempt to elucidate specific roles for individual isoforms in T lymphocyte activation. Using mutationally active PKC isoforms, it has been shown that PKC⑀ and, to a lesser extent, PKC␣ can regulate the transcription factors AP-1 and NF-AT-1 (2) . PKC, which forms part of the supramolecular complex at the interface of the T cell and APC, has been shown to be an upstream regulator of c-Jun N-terminal kinase/stressactivated protein kinase and IL-2 promoter activation in Jurkat T cells (3) (4) (5) . More recently, it has been shown that this isoform synergizes with p95 vav in the activation of the transcription factor NF-B in T cells (6) . Others have used neutralizing isoformspecific Abs to study the role of PKC isoforms in the activation of PBL. These studies demonstrate that PKC␤ and PKC␦ participate in the regulation of IL-2 synthesis, whereas neutralization of PKC␣ and PKC results in inhibition of IL-2R expression (7, 8) .
We have previously shown that a PKC␤-deficient T cell line, K-4, cannot rearrange its microtubule cytoskeleton and therefore cannot display a motile phenotype when stimulated through the adhesion molecule LFA-1 (9) . The parent line, HuT 78, becomes motile when stimulated through LFA-1, with reorganization of the microtubule cytoskeleton. Following activation, PKC␤ relocates from the cytosol to associate with the microtubule cytoskeleton in the area adjacent to the microtubule organizing center (MTOC) and along the dendrite. In mammalian cells, the microtubule cytoskeleton is intimately associated with the secretory process; the Golgi is centred at the MTOC and associates with microtubules and microtubule motors. In addition, the coatomer or coat protein-1 complex, which assembles onto Golgi membranes and is involved in Golgi membrane traffic, associates with signaling molecules including the PKC⑀ isoform (10) .
In contrast to HuT 78, the PKC␤-deficient K-4 cell line does not secrete IL-2 when activated with PMA. Because LFA-1 can transduce an accessory signal for IL-2 secretion in T cells and PKC␤ colocalizes with the microtubule cytoskeleton following activation through LFA-1 (9), the aim of this study was to analyze the specific role of PKC␤ in IL-2 production and secretion. We show that K-4 cells can make IL-2 at the level of both RNA and protein but fail to export the IL-2 from the cell. When PKC␤ was introduced into K-4 cells by microinjection, these cells could secrete IL-2 in response to PMA activation, thus demonstrating a crucial role for PKC␤ in the export of IL-2 from T cells.
Materials and Methods

Cell culture
The human T cell lymphoma cell line HuT 78 (American Type Culture Collection (ATCC), Manassas, VA), the K-4 cell line, generated as described previously (11) , and human PBL were used in this study. Cells were cultured in RPMI 1640 medium containing 10% FCS, L-glutamine, penicillin, and streptomycin. Cultures were set up at a concentration of 1 ϫ 10 6 cells/ml in 24-well plates (Nalge Nunc International, Roskilde, Denmark) for 24 h either alone in the presence of PMA (10 ng/ml) or, in the case of PBL, with anti-CD3, anti-LFA-1, and anti-CD28 or PMA plus PHA (10 g/ml). Anti-CD3 (OKT3) was obtained from ATCC, anti-LFA-1 from Sanbio (Uden, The Netherlands), and anti-CD28 from Alexis (Nottingham, U.K.). PKC inhibitors Go 6976, bisindolylmaleimide (Calbiochem, Nottingham, U.K.), and LY 379196 (a kind gift of Eli Lily, Indianapolis, IN) were added to cells 30 min before addition of stimulus. Supernatants were collected for analysis of cytokine secretion or cells harvested for analysis of IL-2 expression at 24 h following stimulation.
Detection of secreted cytokines
Secreted IL-2 was detected by an ELISA kit (BioSource International, Nivelles, Belgium) according to the manufacturer's instructions.
RNA extraction and RT-PCR
IL-2 mRNA was detected by RT-PCR. Total cellular RNA was prepared using the direct guanidinium isothiocyanate method and transcribed into cDNA using avian myeloblastosis virus reverse transcriptase (Promega Corp, Madison, WN). The cDNA was amplified using 1 U Taq polymerase in a Hybaid OmniGene (Hybaid, Middlesex, U.K.) in 35 cycles (denaturation at 95 C for 3 min, annealing at 60 C for 45 s, and elongation at 72 C for 4 min (one time); denaturation at 95 C for 1 min, annealing at 55 C for 45 s, and elongation at 72 C for 2 min (10 times); denaturation at 95 C for 1 min, annealing at 55 C for 45 s increasing at 0.5 C per cycle, and elongation at 72 C for 2 min increasing at 3 C per cycle (25 times). The following primers were used: IL-2 sense, AACCTCAACTCCTGCCACAATG, and antisense, CAAGTTAGTGTTGAGATGATGC; and ␤-actin sense, TA CATGGCTGGGGTGTTGAA, and antisense, AAGAGAGGCATCCTCAC CCT. The IL-2 primers span three introns, thus controlling for amplification of genomic IL-2 DNA. PCR products were separated in 2% agarose gels and visualized by staining with ethidium bromide.
Detection of intracellular IL-2
Cells were fixed in acetone-formaldehyde (1:1) and permeabilized in 0.5% Triton X-100. IL-2 was detected using a rat anti-IL-2 mAb (BD PharMingen, San Diego, CA) followed by tetramethylrhodamine isothiocyanate-conjugated goat anti-rat (Sigma, Poole, Dorset, U.K.). PKC␤ was detected by a rabbit anti-PKC␤ anti-peptide Ab (Research and Diagnostic Abs, Berkley, CA) followed by FITC-conjugated goat anti-rabbit Ab (Sigma). Microscopic observations and photography were performed on a Nikon TE300 microscope (Nikon, Melville, NY) with a Leica DC100 camera (Leica, Deerfield, IL). For flow cytometry, cells were stained with FITCconjugated rat anti-IL-2 (BD PharMingen).
Immunofluorescent in situ assay for IL-2 secretion
The immunofluorescent in situ assay procedure was largely based on the ELISPOT cytokine detection method with modifications. Single-well chambered glass coverslips (Nalge Nunc International) were treated with 1 mg/ml high m.w. poly(L-lysine) (Sigma) for 1 h at 37 C, washed twice with PBS, and coated with the capture Abs (0.1 mg/ml goat-anti-human IL-2; Sigma) overnight at 4 C. Unbound Abs were removed by gentle doublewash in PBS. Cells were added to the chambers at 1 ϫ 10 5 /ml, allowed to settle, and activated by 10 ng/ml PMA for 12 h (with or without brefeldin A; Sigma). In the experiments with enhanced green fluorescent protein (EGFP) constructs, activation was started after a 2-h recovery interval after microinjection. Cell fixation and immunofluorescent detection of intracellular and captured secreted IL-2 were performed as described above.
Microinjection of EGFP constructs
The EGFP-PKC␤(I) plasmid and "empty" EGFP vector were obtained from Clontech Laboratories (Basingstoke, U.K.). Direct intranuclear microinjection of DNA (0.5 g/l) was conducted within a 10-to 60-min interval after the initial adhesion of the cells to the poly(amino acid)-coated chambered coverslips. On average, 50 -100 cells were injected this way using glass capillary microneedles with Narishige (Tokyo, Japan) microinjection equipment.
Results and Discussion
The T cell lymphoma line HuT 78 secretes high levels of IL-2 in response to PMA activation, whereas the PKC␤-deficient clone K-4 fails to secrete IL-2 in response to this stimulus (Fig. 1a) . A critical role for this PKC␤ isoform is further emphasized by the fact that the classical PKC isoform-specific inhibitor, Go 6976, completely inhibited PMA-stimulated IL-2 secretion in HuT 78 cells (Fig. 1b) . IL-2 production was also inhibited by the mitogenactivated protein/extracellular signal-regulated kinase kinase inhibitor, PD 098059, and the phosphatidylinositol-3 kinase inhibitor, LY 294 002 (data not shown). Stimulation of IL-2 production in PBL either through the TCR alone, through the TCR and accessory molecules LFA-1 and CD28, or using PMA plus PHA was inhibited by Go 6976, the PKC␤ selective inhibitor LY 379196, and the broad spectrum PKC inhibitor bisindolylmaleimide (Fig.  1c) . This indicates that PKC␤ plays a key role in IL-2 production not just in the cell line model system but, importantly, in normal human PBL.
The proinflammatory cytokine TNF is secreted following activation of many cells including monocytes and lymphocytes. The mechanism by which this cytokine is secreted has been previously described; it is expressed as a membrane-bound pro-molecule. Release from the cell is mediated by proteolytic cleavage (12) . Both HuT 78 and K-4 cells secrete TNF when activated with PMA (13). This PMA-stimulated TNF secretion is sensitive to Go 6976, PD 098059, and LY 294 002 (data not shown), suggesting that similar signaling pathways are involved in both TNF and IL-2 production in these cell lines when stimulated with PMA. Given that the PKC␤-deficient cell line K-4 can produce TNF and has a previously characterized defect in microtubule function, we investigated whether these cells could actually make IL-2 at the level of protein.
We postulated that the failure to detect the production of this cytokine may be due to a defect in the classical secretory pathway in which microtubules, together with other functional and signaling molecules, play a crucial role.
First we examined production of IL-2 at the level of mRNA in both cell lines. As demonstrated by RT-PCR, resting K-4 cells express low levels of IL-2 mRNA, which is significantly increased following activation with PMA. By this method, patterns of mRNA expression are the same in HuT 78 and K-4 cells (Fig. 2) . Szamel et al. have shown a correlation between PKC␤ translocation from cytosol to membrane with appearance of IL-2 mRNA at 4 h following T cell activation (8) . However, we now demonstrate the induction of IL-2 message at 24 h following PMA activation even in the absence of PKC␤ expression. Another PKC isoform, PKC, plays a key role in the transcription of the IL-2 gene (14, 15) .
The PKC␤-deficient K-4 cells ( (Fig. 4, a and c) . An EGFP-linked PKC␤ gene was then introduced into K-4 cells by microinjection, and those cells expressing the EGFP-PKC␤ construct were restored with the ability to secrete IL-2 following PMA activation (Fig. 4c) , demonstrating an essential role for this isoform in transporting the cytokine from the T cell. Quantitatively, 76.0 Ϯ 6.5% of EGFP-PKC␤-transfected K-4 cells were able to secrete IL-2, comparable to 87.9 Ϯ 2.7% obtained in the parental HuT 78 cell line (Fig. 4f) . K-4 cells microinjected with an empty EGFP vector were unable to secrete IL-2 in response to PMA (Fig. 4, e and f) . A typical "starburst" IL-2 secretion pattern was abolished in the cells in the presence of brefeldin A (Fig. 4, b, d, and f) .
Studies using a range of PKC activators and inhibitors have demonstrated the involvement of PKC in the secretion of many biological molecules including neurotransmitter release from nerve terminals and amyliod precursor protein secretion from neurons, chloride secretion from epithelial cells, and parietal cell acid (HCl) secretion (16 -19) . However, the subcellular localization and position of PKC isoforms within these secretory processes/cascades has not been well defined. IL-2 is a member of the four ␣ helix bundle cytokine family. Its production is largely controlled by regulation of transcription and message stabilization. Effective mRNA translation is followed by efficient translocation into the endoplasmic reticulum and secretion of the cytokine (20, 21) . PKC has been linked to microtubule function, and there is evidence to suggest that PKC may participate in the Golgi/microtubule-regulated stage of secretion. ␤Ј-coat protein I, which is a coatomer complex protein essential for Golgi budding and vesicular trafficking, has been shown as a PKC⑀-selective receptor for activated C-kinase (10) . This could be a mechanism whereby activated PKC⑀ could regulate Golgi function. In addition, study of secretion of heparan sulfate proteoglycans from HepG2 cells showed that membrane-bound PKC supported vesicle formation with PKC␣ and PKC attaching to highly purified Golgi membranes (22) . We have previously demonstrated that PKC␤ and PKC␦ associate with the microtubule cytoskeleton/MTOC in locomotory T cells, while others have shown that modulation of PKC activity can prevent reorientation of the MTOC in cytotoxic T cells (9, 23) . Phorbol ester-resistant U937 cells display defective microtubule reorganization (24) . This correlated with diminished PKC␤II association with microtubules and loss of heat-soluble microtubule-associated PKC-binding proteins. Microtubule-associated proteins , particularly microtubule-associated protein-2 and -4 are substrates for PKC, and site-specific phosphorylation of these proteins modulates their regulation of tubulin polymerization (25, 26) .
In this study, we have definitively shown that although PKC␤ expression is not necessary for IL-2 transcription or translation, it is essential for the export of the cytokine from the T cell. These findings represent another level of control in IL-2 production and a potential target in immunomodulatory therapy. 
